RPMI 1640 培养基最初是为了悬浮培养人白血病单层细胞而开发的。Roswell Park Memorial Institute (RPMI) 1640 培养基被发现适用于多种哺乳动物细胞,包括了解更多信息
Have Questions?
更改视图
货号
数量
22400105
10 x 500 mL
22400097
100 mL
22400089
500 mL
22400071
1000 mL
22400121
6 x 1000 mL
5 选项
货号 22400105
价格(CNY)
4,666.40
Online Exclusive
Ends: 31-Dec-2026
5,833.00
共减 1,166.60 (20%)
Each
添加至购物车
数量:
10 x 500 mL
Customize this product
价格(CNY)
4,666.40
Online Exclusive
Ends: 31-Dec-2026
5,833.00
共减 1,166.60 (20%)
Each
添加至购物车
RPMI 1640 培养基最初是为了悬浮培养人白血病单层细胞而开发的。Roswell Park Memorial Institute (RPMI) 1640 培养基被发现适用于多种哺乳动物细胞,包括 HeLa 细胞、Jurkat 细胞、 MCF-7 细胞、PC12 细胞、PBMC 细胞、星形胶质细胞和癌细胞。针对广泛的细胞培养应用,我们提供多种组分的 RPMI 1640 改良培养基。使用培养基选择工具查找适合的配方。
Cell-penetrating Peptide enhanced intracellular Raman imaging and photodynamic therapy.
Authors:Fales AM, Yuan H, Vo-Dinh T
Journal:
PubMed ID:23659475
'We present the application of a theranostic system combining Raman imaging and the photodynamic therapy (PDT) effect. The theranostic nanoplatform was created by loading the photosensitizer, protoporphyrin IX, onto a Raman-labeled gold nanostar. A cell-penetrating peptide, TAT, enhanced intracellular accumulation of the nanoparticles in order to improve their delivery and ... More
Slow-cycling therapy-resistant cancer cells.
Authors:Moore N, Houghton J, Lyle S
Journal:Stem Cells Dev
PubMed ID:21973238
Tumor recurrence after chemotherapy is a major cause of patient morbidity and mortality. Recurrences are thought to be secondary to small subsets of cancer cells that are better able to survive traditional forms of chemotherapy and thus drive tumor regrowth. The ability to isolate and better characterize these therapy-resistant cells ... More